Skye Bioscience Inc. (SKYE)
NASDAQ: SKYE
· Real-Time Price · USD
3.53
0.26 (7.95%)
At close: Aug 15, 2025, 3:59 PM
3.51
-0.57%
After-hours: Aug 15, 2025, 07:36 PM EDT
Skye Bioscience Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | 163.39K | 163.39K | 163.39K | 163.39K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 605.74K | 448.46K | 298.64K | 151.72K | 114.51K | 118.64K | 124.25K | 127.41K | 127.43K | 121.19K | 88.02K | 81.21K | 52.4K | 24.72K | 24.72K | n/a | n/a | n/a |
Gross Profit | -605.74K | -448.46K | -298.64K | -151.72K | -114.51K | -118.64K | -124.25K | -127.41K | -127.43K | -121.19K | -88.02K | -56.49K | -27.68K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -50.19M | -40.35M | -34.75M | -28.17M | -43.35M | -37.94M | -34.89M | -33.88M | -12.1M | -12.32M | -12.11M | -11.49M | -10.39M | -9M | -7.85M | -6.71M | -6.42M | -5.82M |
Interest Income | 3.18M | 3.61M | 3.41M | 2.73M | 1.45M | 501.98K | 99.98K | 68.69K | 52.12K | 43.52K | 19.01K | 3.00 | 3.00 | 3.00 | 3.00 | 29.00 | 29.00 | 29.00 |
Pretax Income | -42.37M | -32.64M | -26.56M | -21.23M | -42.28M | -37.49M | -37.64M | -43.11M | -21.29M | -21.6M | -19.47M | -12.1M | -10.79M | -9.4M | -8.52M | -7.51M | -6.98M | -6.38M |
Net Income | -42.37M | -32.65M | -26.57M | -21.24M | -42.29M | -37.5M | -37.65M | -43.12M | -21.3M | -21.61M | -19.48M | -12.1M | -10.8M | -9.4M | -8.52M | -7.51M | -6.98M | -6.38M |
Selling & General & Admin | 17.66M | 18.08M | 17.73M | 15.67M | 13.26M | 10.14M | 7.85M | 6.9M | 5.8M | 6.39M | 6.09M | 5.9M | 6.25M | 5.41M | 4.92M | 4.52M | 4.22M | 4.06M |
Research & Development | 34.21M | 23.95M | 18.7M | 12.5M | 8.87M | 6.58M | 5.82M | 5.76M | 6.29M | 5.93M | 6.01M | 5.59M | 4.13M | 3.59M | 2.93M | 2.19M | 2.21M | 1.75M |
Other Expenses | -6.23M | -6.23M | -6.23M | -4.55M | 21.21M | 21.42M | 21.42M | 27.63M | 6.41M | 6.21M | 6.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 45.64M | 35.8M | 30.19M | 23.61M | 43.35M | 37.79M | 34.73M | 39.93M | 18.15M | 18.52M | 18.31M | 11.46M | 10.36M | 8.97M | 7.82M | 6.71M | 6.42M | 5.82M |
Interest Expense | -136.23K | 313.82K | 749.31K | 1.61M | 1.59M | 1.32M | 906.27K | 645.93K | 585.86K | 604.73K | 785.36K | 814.4K | 798.53K | 783.29K | 769.16K | 757.23K | 744.49K | 726.05K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 45.64M | 35.8M | 30.19M | 23.61M | 43.35M | 37.79M | 34.73M | 39.93M | 18.15M | 18.52M | 18.31M | 11.49M | 10.39M | 9M | 7.85M | 6.71M | 6.42M | 5.82M |
Income Tax Expense | 5.4K | 10.07K | 10.07K | 10.07K | 10.07K | 5.6K | 3.6K | 5.2K | 5.2K | 6.74K | 6.74K | 5.64K | 5.64K | 2.1K | 2.1K | 1.6K | 1.6K | 1.6K |
Shares Outstanding (Basic) | 39.66M | 39.65M | 39.97M | 38.82M | 38.67M | 28M | 12.35M | 7.88M | 3.89M | 3.77M | 2.51M | 1.98M | 1.98M | 1.98M | 1.64M | 1.65M | 1.51M | 1.35M |
Shares Outstanding (Diluted) | 39.66M | 39.65M | 39.97M | 38.82M | 38.67M | 28M | 12.35M | 7.88M | 3.89M | 3.77M | 2.51M | 1.98M | 1.98M | 1.98M | 1.66M | 1.66M | 1.51M | 1.35M |
EPS (Basic) | -1.06 | -0.82 | -0.72 | -0.84 | -3.91 | -4.51 | -5.7 | -10.33 | -8.74 | -9.66 | -9.9 | -6.44 | -5.96 | -6.74 | -6.73 | -6.52 | -6.68 | -6.12 |
EPS (Diluted) | -1.06 | -0.82 | -0.72 | -0.84 | -3.91 | -4.51 | -5.7 | -10.33 | -8.74 | -9.66 | -9.9 | -6.43 | -5.95 | -6.73 | -6.72 | -6.52 | -6.68 | -6.68 |
EBITDA | -41.52M | -31.5M | -25.13M | -19.48M | -40.56M | -36.03M | -36.59M | -42.43M | -20.7M | -20.99M | -18.7M | -11.18M | -9.91M | -8.56M | -7.72M | -6.75M | -6.24M | -5.65M |
EBIT | -42.41M | -32.24M | -25.72M | -19.93M | -40.68M | -36.15M | -36.72M | -42.56M | -20.83M | -21.11M | -18.81M | -11.29M | -10M | -8.62M | -7.75M | -6.75M | -6.24M | -5.65M |
Depreciation & Amortization | 605.74K | 448.46K | 298.64K | 151.72K | 114.51K | 118.64K | 124.25K | 127.41K | 127.43K | 121.19K | 115K | 108.19K | 86.84K | 60.17K | 34.13K | 10.19K | 3.09K | 2.44K |